The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Vitamin K antagonists in heart disease: Current status and perspectives (Section III): Position Paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease
Abstract
Summary: Oral anticoagulants are a mainstay of cardiovascular therapy, and for over 60 years vitamin K antagonists (VKAs) were the only available agents for long-term use. VKAs interfere with the cyclic inter-conversion of vitamin K and its 2,3 epoxide, thus inhibiting γ-carboxylation of glutamate residues at the amino-termini of vitamin K-dependent proteins, including the coagulation factors (F) II (prothrombin), VII, IX and X, as well as of the anticoagulant proteins C, S and Z. The overall effect of such interference is a dose-dependent anticoagulant effect, which has been therapeutically exploited in heart disease since the early 1950s. In this position paper, we review the mechanisms of action, pharmacological properties and side effects of VKAs, which are used in the management of cardiovascular diseases, including coronary heart disease (where their use is limited), stroke prevention in atrial fibrillation, heart valves and/or chronic heart failure. Using an evidence-based approach, we describe the results of completed clinical trials, highlight areas of uncertainty, and recommend therapeutic options for specific disorders. Although VKAs are being increasingly replaced in most patients with non-valvular atrial fibrillation by the new oral anticoagulants, which target either thrombin or FXa, the VKAs remain the agents of choice for patients with atrial fibrillation in the setting of rheumatic valvular disease and for those with mechanical heart valves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
Self-citationGage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
Self-citation2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
Self-citationAuthors/Task Force Members, Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., Flachskampf, F., Hall, R., Iung, B., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,593
Self-citation2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,899
Self-citationApixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
Schömig, A., Neumann, F.-J., Kastrati, A., Schühlen, H., Blasini, R., Hadamitzky, M., Walter, H., Zitzmann-Roth, E.-M., Richardt, G., Alt, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341702 · Cited by 2,028
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
Leon, M. B., Baim, D. S., Popma, J. J., Gordon, P. C., Cutlip, D. E., Ho, K. K. L., Giambartolomei, A., Diver, D. J., Lasorda, D. M., Williams, D. O., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812033392303 · Cited by 1,815
Stroke Prevention in Atrial Fibrillation Study. Final results.
(1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809329 · Cited by 1,577
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
The Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
Dabigatran versus warfarin in patients with mechanical heart valves
Eikelboom, J. W., Connolly, S. J., Brueckmann, M., Granger, C. B., Kappetein, A. P., Mack, M. J., Blatchford, J., Devenny, K., Friedman, J., Guiver, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300615 · Cited by 1,506
Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., et al. (2011) · BMJ · doi:10.1136/bmj.d124 · Cited by 1,428
Self-citationPalareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V., & Singer, D. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022913 · Cited by 1,277
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,160
Canadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,111
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,080
Self-citationHigashi, M. K. (2002) · JAMA · doi:10.1001/jama.287.13.1690 · Cited by 1,048
Warfarin, Aspirin, or Both after Myocardial Infarction
Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., & Arnesen, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020496 · Cited by 846
Self-citationHylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 638
Self-citationAntithrombotic and Thrombolytic Therapy for Valvular Disease
Whitlock, R. P., Sun, J. C., Fremes, S. E., Rubens, F. D., & Teoh, K. H. (2012) · Chest · doi:10.1378/chest.11-2305 · Cited by 625
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Homma, S., Thompson, J. L. P., Pullicino, P. M., Levin, B., Freudenberger, R. S., Teerlink, J. R., Ammon, S. E., Graham, S., Sacco, R. L., Mann, D. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202299 · Cited by 584
Self-citationBertrand, M. E., Legrand, V., Boland, J., Fleck, E., Bonnier, J., Emmanuelson, H., Vrolix, M., Missault, L., Chierchia, S., Casaccia, M., et al. (1998) · Circulation · doi:10.1161/01.cir.98.16.1597 · Cited by 583
Independent predictors of stroke in patients with atrial fibrillation: A systematic review
The Stroke Risk in Atrial Fibrillation Working Group (2007) · Neurology · doi:10.1212/01.wnl.0000267275.68538.8d · Cited by 547
Hart, R. G., Pearce, L. A., McBride, R., Rothbart, R. M., & Asinger, R. W. (1999) · Stroke · doi:10.1161/01.str.30.6.1223 · Cited by 533
Olesen, J., Torp-Pedersen, C., Hansen, M., & Lip, G. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0175 · Cited by 485
Self-citationFriberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · Circulation · doi:10.1161/circulationaha.111.055079 · Cited by 454
Self-citationUrban, P., Macaya, C., Rupprecht, H.-J., Kiemeneij, F., Emanuelsson, H., Fontanelli, A., Pieper, M., Wesseling, T., & Sagnard, L. (1998) · Circulation · doi:10.1161/01.cir.98.20.2126 · Cited by 445
Self-monitoring of oral anticoagulation: a systematic review and meta-analysis
Heneghan, C., Alonso-Coello, P., Garcia-Alamino, J., Perera, R., Meats, E., & Glasziou, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68139-7 · Cited by 438
Lip, G., Lindhardsen, J., Lane, D., Ahlehoff, O., Hansen, M., Raunsø, J., Tolstrup, J., Hansen, P., Gislason, G., Torp-Pedersen, C., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0364 · Cited by 428
Self-citationvan Es, R. F., Jonker, J. J., Verheugt, F. W., Deckers, J. W., & Grobbee, D. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09409-6 · Cited by 423
Self-citationLamberts, M., Olesen, J. B., Ruwald, M. H., Hansen, C. M., Karasoy, D., Kristensen, S. L., Køber, L., Torp-Pedersen, C., Gislason, G. H., & Hansen, M. L. (2012) · Circulation · doi:10.1161/circulationaha.112.114967 · Cited by 413 · cited 1×
“but the risk of bleeding here is clearly higher than with dual therapy (138, 168).”
ResultSelf-citationMassie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Ezekowitz, M., Jafri, S. M., Krol, W. F., O'Connor, C. M., Schulman, K. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.801753 · Cited by 408
Cleland, J. G. F., Findlay, I., Jafri, S., Sutton, G., Falk, R., Bulpitt, C., Prentice, C., Ford, I., Trainer, A., & Poole-Wilson, P. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.010 · Cited by 407
Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Baron-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., Evangelista, A., et al. (2013) · Giornale Italiano di Cardiologia · doi:10.1714/1234.13659 · Cited by 389
Self-citationCohen, M., Adams, P. C., Parry, G., Xiong, J., Chamberlain, D., Wieczorek, I., Fox, K. A., Chesebro, J. H., Strain, J., & Keller, C. (1994) · Circulation · doi:10.1161/01.cir.89.1.81 · Cited by 378
Heneghan, C., Ward, A., Perera, R., Bankhead, C., Fuller, A., Stevens, R., Bradford, K., Tyndel, S., Alonso-Coello, P., Ansell, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61294-4 · Cited by 372
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371
Self-citationWarfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
Limdi, N. A., Wadelius, M., Cavallari, L., Eriksson, N., Crawford, D. C., Lee, M.-T. M., Chen, C.-H., Motsinger-Reif, A., Sagreiya, H., Liu, N., et al. (2010) · Blood · doi:10.1182/blood-2009-12-255992 · Cited by 370
Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 364
Self-citationAntithrombotic Therapy in Atrial Fibrillation
Albers, G. W., Dalen, J. E., Laupacis, A., Manning, W. J., Petersen, P., & Singer, D. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.194s · Cited by 360
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.019 · Cited by 358
Self-citationRecommendations for the management of patients after heart valve surgery
Butchart, E. G., Gohlke-Bärwolf, C., Antunes, M. J., Tornos, P., De Caterina, R., Cormier, B., Prendergast, B., Iung, B., Bjornstad, H., Leport, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi426 · Cited by 358
Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease
Szekely, P. (1964) · BMJ · doi:10.1136/bmj.1.5392.1209 · Cited by 325 · cited 1×
“This situation, of which mitral stenosis is the landmark, is thought to carry the greatest risk of systemic thromboembolism of any common form of acquired native valvular disease, even in the absence of AF, although such estimates are based on old literature (159).”
BackgroundTurpie, A. G. G., Robinson, J. G., Doyle, D. J., Mulji, A. S., Mishkel, G. J., Sealey, B. J., Cairns, J. A., Skingley, L., Hirsh, J., & Gent, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200604 · Cited by 323
Huber, K., Andreotti, F., Arnesen, H., Airaksinen, K. J., Cuisset, T., Kirchhof, P., Marín, F., & Lip, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-08-0580 · Cited by 303
Self-citationComparative Pharmacokinetics of Vitamin K Antagonists
Ufer, M. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544120-00003 · Cited by 303
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 301
Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-11-0784 · Cited by 301
Self-citationCalibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio
Kirkwood, T. B. L. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657371 · Cited by 300
Cairns, J. A., Connolly, S., McMurtry, S., Stephenson, M., & Talajic, M. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.007 · Cited by 292
Andreotti, F., Testa, L., Biondi-Zoccai, G. G. L., & Crea, F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi485 · Cited by 289
Self-citationBleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation
(1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040081009 · Cited by 283
Sato, H., Ishikawa, K., Kitabatake, A., Ogawa, S., Maruyama, Y., Yokota, Y., Fukuyama, T., Doi, Y., Mochizuki, S., Izumi, T., et al. (2006) · Stroke · doi:10.1161/01.str.0000198839.61112.ee · Cited by 282
Hall, P., Nakamura, S., Maiello, L., Itoh, A., Blengino, S., Martini, G., Ferraro, M., & Colombo, A. (1996) · Circulation · doi:10.1161/01.cir.93.2.215 · Cited by 281
Fauchier, L., Hylek, E., Knight, E., Lane, D., Levi, M., Marin, F., Palareti, G., Collet, J.-P., Rubboli, A., Poli, D., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-10-0690 · Cited by 280
Self-citationIncreased embolic risk in patients with left ventricular thrombi.
Stratton, J. R., & Resnick, A. D. (1987) · Circulation · doi:10.1161/01.cir.75.5.1004 · Cited by 276
Knatterud, G. L., Rosenberg, Y., Campeau, L., Geller, N. L., Hunninghake, D. B., Forman, S. A., Forrester, J. S., Gobel, F. L., Herd, J. A., Hickey, A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.157 · Cited by 274
VAN STAA, T. P., SETAKIS, E., DI TANNA, G. L., LANE, D. A., & LIP, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04085.x · Cited by 272
Self-citationEffect of home testing of international normalized ratio on clinical events
Matchar, D. B., Jacobson, A., Dolor, R., Edson, R., Uyeda, L., Phibbs, C. S., Vertrees, J. E., Shih, M.-C., Holodniy, M., & Lavori, P. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002617 · Cited by 266
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
De Caterina, R., Husted, S., Wallentin, L., De Caterina, R., Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.008 · Cited by 265
Self-citationSilent Cerebral Infarction in Patients With Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., James, K. E., Nazarian, S. M., Davenport, J., Broderick, J. P., Gupta, S. R., Thadani, V., Meyer, M. L., & Bridgers, S. L. (1995) · Circulation · doi:10.1161/01.cir.92.8.2178 · Cited by 250
Antiplatelet agents for the treatment and prevention of atherothrombosis
Patrono, C., Andreotti, F., Arnesen, H., Badimon, L., Baigent, C., Collet, J.-P., De Caterina, R., Gulba, D., Huber, K., Husted, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr373 · Cited by 243
Self-citationAnderson, J. L., Horne, B. D., Stevens, S. M., Woller, S. C., Samuelson, K. M., Mansfield, J. W., Robinson, M., Barton, S., Brunisholz, K., Mower, C. P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.070920 · Cited by 229
Lip, G. Y. H., Huber, K., Andreotti, F., Arnesen, H., Airaksinen, J. K., Cuisset, T., Kirchhof, P., & Marin, F. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq117 · Cited by 229
Self-citationFiore, L. D., Ezekowitz, M. D., Brophy, M. T., Lu, D., Sacco, J., & Peduzzi, P. (2002) · Circulation · doi:10.1161/hc0502.103329 · Cited by 224
Multicentre randomised study of computerised anticoagulant dosage
Poller, L., Shiach, C., MacCallum, P., Johansen, A., Münster, A., Magalhäes, A., & Jespersen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04147-6 · Cited by 222
Self-citationEfficacy of Antithrombotic Therapy in Chronic Heart Failure: The HELAS Study
Cokkinos, D. V., Haralabopoulos, G. C., Kostis, J. B., Toutouzas, P. K., & for the HELAS investigators (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.02.012 · Cited by 217
OLESEN, J. B., LIP, G. Y. H., HANSEN, P. R., LINDHARDSEN, J., AHLEHOFF, O., ANDERSSON, C., WEEKE, P., HANSEN, M. L., GISLASON, G. H., & TORP‐PEDERSEN, C. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04378.x · Cited by 201
Self-citationRoldán, V., Marín, F., Fernández, H., Manzano-Fernandez, S., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Chest · doi:10.1378/chest.12-0608 · Cited by 193
Self-citationVan de Werf, F., Brueckmann, M., Connolly, S. J., Friedman, J., Granger, C. B., Härtter, S., Harper, R., Kappetein, A. P., Lehr, T., Mack, M. J., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.03.011 · Cited by 185
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance
Loebstein, R., Dvoskin, I., Halkin, H., Vecsler, M., Lubetsky, A., Rechavi, G., Amariglio, N., Cohen, Y., Ken-Dror, G., Almog, S., et al. (2007) · Blood · doi:10.1182/blood-2006-08-038984 · Cited by 171
Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study
Chiang, C.-W., Lo, S.-K., Ko, Y.-S., Cheng, N.-J., Lin, P. J., & Chang, C.-H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00001 · Cited by 165
Omran, H., Bauersachs, R., Rübenacker, S., Goss, F., & Hammerstingl, C. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-12-0827 · Cited by 164
International Normalized Ratios (INR): the first 20 years
Poller, L. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00775.x · Cited by 157
Anticoagulants in heart disease: current status and perspectives
Caterina, R. D., Husted, S., Wallentin, L. C., Agnelli, G., Bachmann, F., Baigent, C., Jespersen, J., Kristensen, S., Montalescot, G., Siegbahn, A. G., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl492 · Cited by 147
Self-citationThe CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?
Eikelboom, J. W., & Karthikeyan, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-11-0757 · Cited by 146
Brouwer, M. A., van den Bergh, P. J. P. C., Aengevaeren, W. R. M., Veen, G., Luijten, H. E., Hertzberger, D. P., Boven, A. J. V., Vromans, R. P. J. W., Uijen, G. J. H., & Verheugt, F. W. A. (2002) · Circulation · doi:10.1161/01.cir.0000024408.81821.32 · Cited by 146
Self-citationLópes, R. D., Hylek, E. M., & Garcia, D. A. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-07-0491 · Cited by 134
Risk Factors for Thromboembolic Complications in Chronic Atrial Fibrillation
Petersen, P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.819 · Cited by 130
Ventricular thrombi and thromboembolism in dilated cardiomyopathy: A prospective follow-up study
Falk, R. H., Foster, E., & Coats, M. H. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90757-m · Cited by 126
Lin, L., Lee, C., Yu, C., Tsai, C., Lai, L.-P., Hwang, J., Chen, P., & Lin, J.-L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.033 · Cited by 124
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M., Raskob, G. E., Landefeld, S., & Kearon, C. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.511s · Cited by 124
Poller, L., Keown, M., Ibrahim, S. A., Lowe, G. D. O., Moia, M., Turpie, A. G. G., Roberts, C., van den Besselaar, A. M. H. P., van der Meer, F. J. M., Tripodi, A., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02959.x · Cited by 120
Self-citationGadisseur, A., Breukink-Engbers, W. G. M., van der Meer, F. J. M., van den Besselaar, A. M. H. P., Sturk, A., & Rosendaal, F. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.21.2639 · Cited by 118
ANTICOAGULANTSINTHESECONDARYPR (1994) · The Lancet · doi:10.1016/s0140-6736(94)91458-3 · Cited by 117
Drug interactions with warfarin: what clinicians need to know
Juurlink, D. N. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070946 · Cited by 113
Faxon, D. P., Eikelboom, J. W., Berger, P. B., Holmes, D. R., Bhatt, D. L., Moliterno, D. J., Becker, R. C., & Angiolillo, D. J. (2011) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.111.965186 · Cited by 108
van Schie, R. M., Wessels, J. A. M., le Cessie, S., de Boer, A., Schalekamp, T., van der Meer, F. J. M., Verhoef, T. I., van Meegen, E., Rosendaal, F. R., der Zee, A. H. M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr116 · Cited by 106
Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation
Frost, L., Engholm, G., Johnsen, S. P., Møller, H., & Husted, S. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00415-5 · Cited by 103
Self-citationMassie, B. M., Krol, W. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Collins, J. F., Ezekowitz, M. D., Jafri, S. M., O’Connor, C. M., Packer, M., et al. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.02.006 · Cited by 101
Christensen, T. D., & Larsen, T. B. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04568.x · Cited by 99
Cohen, M. C., Adams, P. C., Hawkins, L. A., Bach, M., & Fuster, V. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91155-y · Cited by 95
Prediction of Warfarin Dose: Why, When and How?
Eriksson, N., & Wadelius, M. (2012) · Pharmacogenomics · doi:10.2217/pgs.11.184 · Cited by 93
Frykman, V. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2300 · Cited by 93
Assessing the Risk of Bleeding in Patients With Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Lagrenade, I., Lane, D. A., Taillandier, S., & Fauchier, L. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.972869 · Cited by 90
Self-citationSchulman, S., Parpia, S., Stewart, C., Rudd-Scott, L., Julian, J. A., & Levine, M. N. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-10-201111150-00003 · Cited by 86
Smith, J. G., Wieloch, M., Koul, S. M., Braun, O. Ö., Lumsden, J., Rydell, E., Öhman, J. N., Scherstén, F., Svensson, P. J., & van der Pals, J. (2012) · EuroIntervention · doi:10.4244/eijv8i6a105 · Cited by 85
Ellis, D., Usman, M. H., Milner, P. G., Canafax, D. M., & Ezekowitz, M. D. (2009) · Circulation · doi:10.1161/circulationaha.109.856120 · Cited by 85
The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01118-9 · Cited by 83
Warfarin and vitamin K intake in the era of pharmacogenetics
Lurie, Y., Loebstein, R., Kurnik, D., Almog, S., & Halkin, H. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03672.x · Cited by 82
Apostolakis, S. Z., Lane, D. A., Guo, Y., Buller, H. R., & Lip, G. Y. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.010 · Cited by 81
Self-citationGuo, Y., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.052 · Cited by 80
Self-citationPonikowski, P. P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., Morais, J., Pullicino, P. M., Rasmussen, L., Marín, F. R., Lane, D. A., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0578 · Cited by 74
Self-citationAiraksinen, J. K. E., Cuisset, T., Marín, F. R., Rubboli, A., Rubboli, A., Lip, G. Y. H., & Huber, K. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0602 · Cited by 72
Self-citationFERDER, N. S., EBY, C. S., Birman-Deych, E., Harris, J. K., Ridker, P. M., Milligan, P. E., Goldhaber, S. Z., KING, C. R., Giri, T. K., McLeod, H. L., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03677.x · Cited by 72
Ansell, J. (2012) · Circulation · doi:10.1161/circulationaha.111.031153 · Cited by 71
Borobia, A. M., Lubomirov, R., Ramı́rez, E., Lorenzo, A., Campos, A., Romo, R. M., Fernández‐Capitán, C., Frías, J., & Carcas, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041360 · Cited by 65
Lip, G. Y. H., Lin, H., Chien, K., Hsu, H., Su, T., Chen, M.-F., & Lee, Y. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.148 · Cited by 65
Self-citationSystematic review of studies of self-management of oral anticoagulation
Berghold, A., Sawicki, P. T., & Siebenhofer, A. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-09-0598 · Cited by 63
ten Berg, J. M., Kelder, J. C., SUTTORP, M. J., Mast, E. G., Bal, E. T., Ernst, S. M. P. G., Verheugt, F. W. A., & Plokker, H. W. T. (2000) · Circulation · doi:10.1161/01.cir.102.4.386 · Cited by 63
Self-citationA differential effect of aspirin on prevention of stroke in atrial fibrillation
(1993) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/s1052-3057(10)80159-4 · Cited by 63
Liang, R., Li, L., Li, C., Gao, Y., Liu, W., Hu, D., & Sun, Y. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0725-7 · Cited by 62
Herlitz, J. D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.026 · Cited by 60
Effect of Rosuvastatin on Warfarin Pharmacodynamics and Pharmacokinetics
Simonson, S. G., Martin, P. D., Mitchell, P., Lasseter, K. C., Gibson, G. L., & Schneck, D. W. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005278224 · Cited by 52
Rasmussen, L. H., Larsen, T. B., Due, K. M., Tjønneland, A. M., Overvad, K., & Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04308.x · Cited by 48
Self-citationAndersson, M. L., Eliasson, E., & Lindh, J. D. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.40 · Cited by 43
Blood Coagulation in Patients with Chronic Heart Failure
Lorenzo, F. D., Saba, N., & Kakkar, V. V. (2003) · Drugs · doi:10.2165/00003495-200363060-00004 · Cited by 40
Clarke, K., Taberner, D. A., THOMSON, J. M., Morris, J. A., & Poller, L. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.1.58 · Cited by 38
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0685 · Cited by 31
Self-citationGains and losses of warfarin therapy as performed in an anticoagulation clinic
Njaastad, A. M., Abildgaard, U., & Lassen, J. F. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01605.x · Cited by 30
Poller, L., Ibrahim, S., Keown, M., Pattison, A., & Jespersen, J. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04109.x · Cited by 25
Self-citationPlenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic
Skov, J., Bladbjerg, E., Sidelmann, J. J., Vámosi, M., & Jespersen, J. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1045-0 · Cited by 23
Self-citationPoller, L., Ibrahim, S., Keown, M., Pattison, A., & Jespersen, J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.141937 · Cited by 21
Self-citationGenotype-Based Dosing Algorithms for Warfarin Therapy
Johnson, E., Horne, B. D., Carlquist, J. F., & Anderson, J. L. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256417 · Cited by 18
van Schie, R. M., BABAJEFF, A. M. V., Schalekamp, T., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04694.x · Cited by 17
Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians
Comets, E., Diquet, B., Legrain, S., Huisse, M., Godon, A., Bruhat, C., Chauveheid, M., Delpierre, S., Duval, X., Berrut, G., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.309 · Cited by 10
New Therapies for Stroke Prevention in Atrial Fibrillation: The Long Road to Enhanced Efficacy
Freedman, J. E., & Gersh, B. J. (2009) · Circulation · doi:10.1161/circulationaha.109.893362 · Cited by 9
Poller, L., Jespersen, J., Ibrahim, S. A., & Pattison, A. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12164 · Cited by 8
Self-citationAntithrombotic Management in Patients with Prosthetic Valves
Butchart, E. G., & Caterina, R. D. (2012) · Wiley eBooks · doi:10.1002/9781118410875.ch17 · Cited by 5
Self-citation
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationVan Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Self-citation
Metadata
- Authors
- Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., Morais, J., Rasmussen, L. H., Siegbahn, A., Verheugt, F. W. A., Weitz, J. I., & Caterina, R. D.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2013
- Volume
- 110
- Issue
- 12
- Pages
- 1087-1107
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W4297900745
- Cited by
- 365
- References
- 145
- FWCI
- 40.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.